Description:
* "Botry-Zen
Limited was formed in April 2001 to research, develop and commercialise
biological control agents for use in the agriculture and horticulture
industry. The company is publicly listed on the New Zealand Stock
Exchange’s Main Board. Click here to view the Company's
Listing Profile. The
first biological control agent to be released commercially by Botry-Zen
Limited is a new product called BOTRY-Zen
which was specifically developed for the effective control of Botrytis
cinerea fungal infection in grapes ("bunch rot"or "grey
mould"). Botry-Zen Limited (the company) owns an exclusive licence to
technology giving the company the ability to produce, distribute and sell
BOTRY-Zen (the product). The
technology was developed through the co-operative efforts of the
Horticulture Food Research Institute of New Zealand Limited (HortResearch),
Winegrape Tech (a joint venture between Winegrowers
of New Zealand Limited and New Zealand Grape Growers Limited) and
Zenith Technology Corporation Limited (Zentech)
and is the subject of an international patent application."
Website: http://www.botryzen.co.nz/
Recent announcements: click here
|
Year |
2002 |
2003 |
2004 |
2005 |
2006 |
Average
GR |
Compounding
GR |
|
Gross
growth rates |
|
|
|
|
|||
|
Revenue |
|
-8% |
-9% |
4% |
43% |
36% |
5% |
|
NPAT |
|
20% |
20% |
-41% |
108% |
92% |
12% |
|
Total
Assets |
|
-24% |
-40% |
-40% |
206% |
120% |
-3% |
|
Net
Assets |
|
-26% |
-42% |
-43% |
231% |
140% |
-4% |
|
Per
Share figures and growth |
|||||||
|
Earnings |
$
(0.01) |
$
(0.01) |
$
(0.01) |
$
(0.00) |
$
(0.01) |
|
|
|
|
|
20% |
20% |
-41% |
127% |
110% |
14% |
|
Net
Assets |
$
0.02 |
$
0.02 |
$
0.01 |
$
0.01 |
$
0.02 |
|
|
|
|
|
-26% |
-42% |
-43% |
260% |
169% |
-2% |
|
Dividends |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profitability |
|||||||
|
Return
on Assets |
-21% |
-34% |
-67% |
-67% |
-45% |
|
|
|
Equity
Multiplier |
1.01 |
1.04 |
1.08 |
1.13 |
1.04 |
|
|
|
Return
on Equity (ROE) |
-22% |
-35% |
-72% |
-75% |
-47% |
|
|
|
ROE
(avg E) |
|
-30% |
-53% |
-55% |
-73% |
|
|
|
Net
Profit Margin |
-402% |
-522% |
-682% |
-390% |
-569% |
|
|
|
Dividend
payout ratio |
0% |
0% |
0% |
0% |
0% |
|
|
|
Liquidity |
|||||||
|
Net
working capital |
$3,492,644
|
$2,156,208
|
$
775,055 |
$
652,014 |
$2,680,119
|
|
|
|
Current
ratio |
72.12 |
17.30 |
6.48 |
6.01 |
19.59 |
|
|
|
Acid
test ratio |
72.11 |
17.30 |
6.48 |
6.01 |
19.59 |
|
|
|
Other |
|||||||
|
Times
interest earned |
|
|
|
|
|
|
|
|
Operating
exp/income |
205% |
579% |
731% |
692% |
649% |
|
|
|
|
|
|
|
|
|
|
|
|
Summary
Financials |
|||||||
|
Income |
221859 |
204415 |
186973 |
660199 |
277314 |
|
|
|
Expenses |
1113846 |
1271386 |
1462328 |
1417945 |
1856334 |
|
|
|
Tax |
0 |
0 |
0 |
0 |
0 |
|
|
|
NPAT |
-891987 |
-1066971 |
-1275355 |
-757746 |
-1579020 |
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
4158121 |
3174313 |
1908212 |
1139034 |
3484148 |
|
|
|
Liabilities |
49108 |
132271 |
141524 |
130092 |
144193 |
|
|
|
Net
Assets |
4109013 |
3042042 |
1766688 |
1008942 |
3339955 |
|
|
| Registered Office: Level One 30 London Street Dunedin |
Mailing address: |
| Directors: Dr Maxwell Gilbert Shepherd Dr Wayne Leonard Burt Dr John William Forrest Mr John William Gilks Dr Cheung-Tak Hung Mr David John Smallbone |
Secretary: |
| Auditors: Deloitte |
Solicitors: Anderson Lloyd Caudwell Kensington Swan |
| Bankers: The Bank of New Zealand The National Bank of New Zealand |
Registrar: Link Market Services |
| Other: |
|
| Other | Last updated:14-11-2007 |
Company balance date: 31 March
Trading over the last year
